Abstract Background and Objectives Ramucirumab is a fully immunoglobulin G (lgG)
monoclonal antibody targeting vascular endothelial growth factor receptor type 2 (VEGFR2) …

Novel agents to reduce angiogenesis by targeting vascular endothelial growth factor and
other proangiogenic signaling pathways are being developed for advanced nonsmall cell …

Background Pneumatosis intestinalis (PI) is defined as the presence of gas in the bowel wall
and is a relatively rare finding. PI has been associated with various pathological conditions …

A 53-years-old woman presented with sudden abdominal pain. One year before, she was
diagnosed an inflammatory ductal carcinoma of the left breast (T3N0M0) and received 6 …

Cancer represents one of the most up to date issues worldwide because of the increasing
number of affected people and the impact of it on the families and health system. It is one of …

Background and aims Plaque progression increases the risk of a cardiovascular event. This
study aims to determine whether intraplaque neovascularization (NV) associates with a …

BACKGROUND In driver gene-negative non-small cell lung cancer patients who relapse
following radical resection, combination chemotherapy using bevacizumab and platinum …

OBJECTIVE: To identify those patients with gynecologic cancers and intestinal perforation in
whom conservative management may be appropriate. METHODS: A retrospective review …

Sunitinib, a multitargeted tyrosine kinase inhibitor, is widely used in the treatment of
carcinoma. Adverse events associated with this treatment, including fatigue, diarrhea, and …

Angiogenesis refers to the growth of newly formed blood vessels from pre-existing
vasculature (Wang et al., Oncotarget. 8: 53854–72, 2017). Blocking the formation of blood …